Trial intelligence / Profile preview

Influence of Aliskiren on Albuminuria After Kidney Transplantation

NCT02446548Completed

Sponsor
Medical University of Gdańsk
Start
Mar 2013
Primary completion
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of aliskiren in albuminuria (2 arms), sponsored by Medical University of Gdańsk. Primary endpoint: Difference in albuminuria at 8 weeks. Started Mar 2013; status: completed.

02

Drugs

aliskiren
03

Conditions

albuminuria

Beyond the preview

Go deeper on NCT02446548.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02446548.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call